Not provided
Not provided
Not provided
Not provided
Not provided
Lack of recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Amphia ziekenhuis, Oosterhout, The Netherlands | UNKNOWN |
This study evaluates the Freedom SCS (spinal cord stimulation) System for the treatment of chronic back and leg pain. Patients who have been diagnosed with failed back surgery syndrome (FBSS) will receive a stimulator device for treatment of their pain.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Back Pain Only | Active Comparator | Pain localized to the low back or buttocks. |
|
| Leg Pain Only | Active Comparator | Pain localized to unilateral pain of the leg (thigh, knee, calf, or foot). |
|
| Back and Leg Pain | Active Comparator | Pain localized to both the low back and legs (back, buttocks, thigh, knee, calf, or foot). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Freedom Spinal Cord Stimulator System | Device |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of pain relief experienced in the area of pain identified at baseline compared to 12 months post full implant of the Freedom SCS system. | Self reported pain intensity measured by the Visual Analog Scale (VAS) | 12 months |
| Incidence and severity of device related adverse events during the study. | Up to 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| To assess compliance data to indicate usability of the device. | Questionnaire | 12 Months |
| To assess the implanters' experience with the device. | Questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Greg Jansen | Amphia ziekenhuis Oosterhout | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Amphia Ziekenhuis | Oosterhout | North Brabant | 4900 | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
| Average of 7 days after implant |
| Patient satisfaction with treatment. | Questionnaire | 12 Months |
| Reduced visits to health care institutes for chronic back and leg pain. | Questionnaire | 12 Months |
| Improved work status. | Questionnaire | 12 Months |
| Improved quality of life function via the ODI and EQ-5D questionnaires | ODI and EQ-5D Questionnaires | 12 Months |
| Reduction in use of analgesics | 12 Months |
| Reduced operating theater time | Review of hospital records | Average of 7 days after implant |
| Reduced skin to skin time | Review of hospital records | Average of 7 days after implant |
| Reduced skin to fluoroscope time | Review of hospital records | Average of 7 days after implant |
| To monitor non-device and non-SCS-related adverse events | Up to 12 months |